{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:29:42Z","timestamp":1793806182759,"version":"4.6.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Isolated hyperthermic limb perfusion (ILP) is a limb-salvage technique used in the treatment of malignant melanoma and soft tissue sarcomas with in-transit or locally advanced disease. ILP allows regional administration of high-dose chemotherapy with minimal systemic toxicity. This study aims to evaluate postoperative complications and identify predictive factors influencing outcomes in patients undergoing ILP. We retrospectively analyzed 49 patients with malignant melanoma or extremity soft tissue sarcoma who underwent ILP at a single tertiary center between 2014 and 2024. Complications were classified using the Clavien-Dindo system; toxicity was graded via the Wieberdink scale. Logistic regression and univariate analyses were used to evaluate clinical, surgical, and laboratory parameters predictive of severe complications, toxicity, and mortality. Of the patients, 32 (65.3%) experienced complications, primarily within the first 3 postoperative days. Severe complications (Clavien-Dindo grade\u2005\u2265\u20053) occurred in 11 patients (22.4%). Severe regional toxicity (Wieberdink grade\u2005\u2265\u20054) was observed in 6.1%. Early mortality occurred in 3 cases. Preoperative and postoperative albumin levels, along with C-reactive protein levels on postoperative days 3 and 5, were significantly associated with severe complications. No significant relationship was found between modified Systemic Inflammation Scores and postoperative outcomes. ILP remains a valuable regional treatment option for carefully selected patients with advanced melanoma and extremity soft tissue sarcoma. Preoperative nutritional status and early postoperative inflammatory markers, particularly albumin and C-reactive protein, may serve as valuable predictors for adverse outcomes. Optimization of these parameters could improve postoperative recovery and treatment planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050929","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:57Z","timestamp":1790359317000},"page":"e50929","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing isolated limb perfusion in malignant melanoma and sarcoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Veysel Cem","family":"\u00d6zcan","sequence":"first","affiliation":[{"name":"Surgical Oncology Department, Antalya City Hospital, Antalya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-1284","authenticated-orcid":false,"given":"Ezgi","family":"Altinsoy","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Van Training and Research Hospital, Van, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Ba\u015fpinar","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Ordu University Training and Research Hospital, Ordu, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail Can","family":"Tercan","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Diyarbakir Gazi Ya\u015fargil Training and Research Hospital, Diyarbakir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firat","family":"Teke\u015f","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Ankara Etlik City Hospital, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Tamam","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Ankara University Faculty of Medicine, Ankara, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"\u00c7ulcu","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Ankara University Faculty of Medicine, Ankara, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ekrem","family":"\u00dcnal","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, Ankara University Faculty of Medicine, Ankara, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma.","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.3747\/co.27.6523","article-title":"Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.","volume":"27","author":"Wright","year":"2020","journal-title":"Curr Oncol"},{"key":"R6-20261104","first-page":"95","article-title":"WHO classification of soft tissue tumors: an update based on the 2013 (4th) edition.","volume":"46","author":"Jo","year":"2014","journal-title":"Pathology (Phila)"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.","volume":"359","author":"O\u2019Sullivan","year":"2002","journal-title":"Lancet"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jamcollsurg.2016.12.035","article-title":"Isolated limb infusion as a limb salvage strategy for locally advanced extremity sarcoma.","volume":"224","author":"Mullinax","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/CMR.0b013e32832985e3","article-title":"Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.","volume":"19","author":"Brady","year":"2009","journal-title":"Melanoma Res"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1477-7819-12-81","article-title":"Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation.","volume":"12","author":"Podleska","year":"2014","journal-title":"World J Surg Oncol"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.ejso.2016.02.250","article-title":"Calculating regional tissue volume for hyperthermic isolated limb perfusion: four methods compared.","volume":"42","author":"Cecchin","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1054\/bjoc.1999.1032","article-title":"Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.","volume":"82","author":"de Wilt","year":"2000","journal-title":"Br J Cancer"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12032-012-0432-4","article-title":"Pretreatment neutrophil\/lymphocyte ratio is superior to platelet\/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.","volume":"30","author":"Azab","year":"2013","journal-title":"Med Oncol"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12032-012-0439-x","article-title":"Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.","volume":"30","author":"He","year":"2013","journal-title":"Med Oncol"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/sj.bjc.6602591","article-title":"A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.","volume":"92","author":"Forrest","year":"2005","journal-title":"Br J Cancer"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.surg.2007.12.014","article-title":"The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.","volume":"143","author":"Smith","year":"2008","journal-title":"Surgery"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00595-009-4065-y","article-title":"Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma.","volume":"40","author":"Nozoe","year":"2010","journal-title":"Surg Today"},{"key":"R19-20261104","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3747\/co.v17i4.567","article-title":"The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.","volume":"17","author":"Kasymjanova","year":"2010","journal-title":"Curr Oncol"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12957-021-02437-6","article-title":"The diagnostic value of modified systemic inflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent isolated limb perfusion.","volume":"19","author":"Morkavuk","year":"2021","journal-title":"World J Surg Oncol"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.3390\/cancers13215485","article-title":"Role of isolated limb perfusion in the era of targeted therapies and immunotherapy in melanoma. A systematic review of the literature.","volume":"13","author":"Sevilla-Ortega","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1245\/s10434-018-07143-4","article-title":"Response and toxicity of repeated isolated limb perfusion (re-ILP) for patients with in-transit metastases of malignant melanoma.","volume":"26","author":"Belgrano","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/jpm14050442","article-title":"Isolated limb perfusion and immunotherapy in the treatment of in-transit melanoma metastases: is it a real synergy?","volume":"14","author":"Rastrelli","year":"2024","journal-title":"J Pers Med"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/ejso.2001.1124","article-title":"Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor-alpha versus toxicity after melphalan alone.","volume":"27","author":"Vrouenraets","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"R25-20261104","doi-asserted-by":"crossref","first-page":"1531987","DOI":"10.3389\/fonc.2025.1531987","article-title":"Relationship between nutritional-inflammatory markers and postoperative outcomes in ovarian cancer: a retrospective study.","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"key":"R26-20261104","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis.","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:20Z","timestamp":1793804540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050929"}},"subtitle":["Key factors influencing postoperative outcomes and complications"],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":24,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050929","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2026-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}